Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Annette North currently holds 11,696 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Annette North has been a net seller of TPTX stock. They have purchased $0 and sold $7.3M worth of shares.
Annette North's most recent insider trade was on Feb 9, 2022, when they sold 669 shares at $36.30 per share.
Annette North serves as Executive at Turning Point Therapeutics, Inc. (TPTX). They have executed 28 insider transactions totaling $7.3M over their tenure at the company.
Annette North holds the position of Executive at Turning Point Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Annette North has shown a selling trading pattern, with $0 in total purchases and $7.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Annette North was on Feb 1, 2021, when they sold $1.3M worth of TPTX shares. This transaction involved 10,541 shares at $123.49 per share.
Annette North currently owns 11,696 shares of Turning Point Therapeutics, Inc. (TPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Annette North's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Annette North has 28 Form 4 filings on record as an insider at Turning Point Therapeutics, Inc..
Set alerts for Annette North and 40,000+ other insiders.